Biotechnology Stocks
| # | Últimos 7 dias | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3580 | KROS Keros Therapeutics, Inc. - common stock | 10.83 USD | -1.81% | +7.76% | +6.59% | -28.28% | 214.73 M USD | ||
| 3582 | PEPG PepGen Inc. - Common Stock | 3.08 USD | -1.91% | +4.76% | +57.95% | +133.33% | 213.32 M USD | ||
| 3584 | SLGL Sol-Gel Technologies Ltd. - Ordinary Shares | 77.12 USD | -0.78% | -8.18% | -6.36% | +243.06% | 214.87 M USD | ||
| 3589 | TNXP Tonix Pharmaceuticals Holding Corp. - Common Stock | 12.40 USD | -1.20% | -1.43% | +24.12% | -17.39% | 212.67 M USD | ||
| 3597 | ACOG Alpha Cognition Inc. - Common Stock | 9.82 USD | +0.72% | +15.53% | +20.64% | +29.38% | 213.86 M USD | ||
| 3599 | IPHA Innate Pharma S.A. - American Depositary Shares | 2.20 USD | -2.65% | +1.85% | +19.57% | -3.08% | 206.18 M USD | ||
| 3607 | VYGR Voyager Therapeutics, Inc. - Common Stock | 3.28 USD | -3.24% | +0.92% | +5.47% | -29.46% | 202.11 M USD | ||
| 3621 | CRBP Corbus Pharmaceuticals Holdings, Inc. - Common Stock | 9.80 USD | -5.59% | -5.13% | +6.29% | -40.96% | 189.54 M USD | ||
| 3625 | ORMP Oramed Pharmaceuticals Inc. - Common Stock | 4.76 USD | -1.04% | +7.21% | +17.24% | +119.35% | 198.00 M USD | ||
| 3645 | KRRO Korro Bio, Inc. - Common Stock | 12.76 USD | -3.19% | -2.60% | +16.74% | -67.20% | 187.90 M USD | ||
| 3651 | PLX Protalix BioTherapeutics, Inc. Common Stock | 2.36 USD | -0.42% | +3.06% | -2.48% | -19.18% | 190.15 M USD | ||
| 3653 | NKTX Nkarta, Inc. - Common Stock | 2.51 USD | -5.64% | +6.81% | +9.61% | +5.91% | 179.78 M USD | ||
| 3654 | ADAG Adagene Inc - ADS, each representing 1.25 | 3.89 USD | -3.23% | +4.85% | +18.96% | +60.74% | 184.33 M USD | ||
| 3663 | ARMP Armata Pharmaceuticals, Inc. Common Stock | 4.98 USD | -1.39% | +10.91% | +10.42% | -39.05% | 185.17 M USD | ||
| 3675 | QSI Quantum-Si Incorporated - Class A Common Stock | 0.79 USD | -5.95% | +2.60% | 0.00% | -30.09% | 172.92 M USD | ||
| 3678 | CDXS Codexis, Inc. - Common Stock | 1.71 USD | +2.40% | +7.55% | +14.77% | -40.42% | 187.25 M USD | ||
| 3691 | CRBU Caribou Biosciences, Inc. - Common Stock | 1.63 USD | -1.81% | +3.16% | +1.87% | -9.44% | 174.75 M USD | ||
| 3693 | HUMA Humacyte, Inc. - Common Stock | 0.66 USD | +3.12% | +13.79% | +3.13% | -57.69% | 183.35 M USD | ||
| 3695 | MOLN Molecular Partners AG - American Depositary Shares | 4.30 USD | -2.27% | +1.18% | +7.23% | +10.54% | 173.61 M USD | ||
| 3702 | CUE Cue Biopharma, Inc. - Common Stock | 23.25 USD | -3.04% | -27.91% | -29.35% | +2701.20% | 168.90 M USD |
Notícias Biotechnology Stocks
Dinamarca - Ações fecharam o pregão em alta e o Índice OMX Copenhagen 20 avançou 0,41%
Deutsche Bank rebaixa argenx para neutro após valorização expressiva
Por que as ações da Monte Rosa Therapeutics estão caindo hoje?
Ações da Biomea Fusion disparam com conclusão de inscrições em estudo sobre diabetes
Ações da Monte Rosa caem com início de estudo de fase 2 contra câncer de próstata
Ação da Crinetics Pharmaceuticals atinge máxima histórica de US$ 84,80
H.C. Wainwright reitera recomendação para Biomea Fusion após conclusão de recrutamento em ensaio clínico
Gainers Biotechnology Stocks
SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
OABIW OmniAb, Inc. - Warrant | 0.2339 | +37.59% |
LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
Losers Biotechnology Stocks
HUMAW Humacyte, Inc. - Warrant | 0.0050 | -44.44% |
CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |
SNTI Senti Biosciences, Inc. - Common Stock | 0.35 | -10.26% |